Clinical Trials Browser

Phase 2 × Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction × apatinib × Clear all

NCT03030937 2017-01-25

Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA

Phase 2 Unknown

Gastrointestinal

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction